|
LLGL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.977000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.531800E-01 |
| Normal-vs-Stage2 |
2.757600E-01 |
| Normal-vs-Stage3 |
5.666400E-01 |
| Normal-vs-Stage4 |
7.955700E-02 |
| Stage1-vs-Stage2 |
4.996800E-01 |
| Stage1-vs-Stage3 |
3.453400E-01 |
| Stage1-vs-Stage4 |
1.361960E-01 |
| Stage2-vs-Stage3 |
2.259600E-01 |
| Stage2-vs-Stage4 |
2.153200E-01 |
| Stage3-vs-Stage4 |
8.662300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.567400E-01 |
| Normal-vs-AfricanAmerican |
1.747210E-01 |
| Normal-vs-Asian |
7.013400E-01 |
| Caucasian-vs-AfricanAmerican |
1.206400E-01 |
| Caucasian-vs-Asian |
7.057800E-01 |
| AfricanAmerican-vs-Asian |
9.178000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.707190E-01 |
| Normal-vs-Female |
1.794070E-02 |
| Male-vs-Female |
8.231600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.830600E-01 |
| Normal-vs-Extreme_Weight |
9.550200E-02 |
| Normal-vs-Obese |
6.756000E-01 |
| Normal-vs-Extreme_Obese |
9.722200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.214400E-01 |
| Normal_Weight-vs-Obese |
4.970000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.189200E-01 |
| Extreme_Weight-vs-Obese |
7.596500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.579400E-01 |
| Obese-vs-Extreme_Obese |
8.844800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.998230E-01 |
| Normal-vs-Age(41-60Yrs) |
3.402400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.485600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.342990E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.223200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.571600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.616100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.368500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.364300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.573600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.061200E-01 |
| Normal-VS-Type2 PRCC |
2.564200E-02 |
| Normal-VS-KIRP CIMP |
1.409220E-01 |
| Normal-VS-Unclassified PRCC |
1.299590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.679900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.269900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.768770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.260700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.020200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.601400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.925900E-02 |
| Normal-vs-N1 |
5.856600E-01 |
| Normal-vs-N2 |
7.523600E-01 |
| N0-vs-N1 |
1.113000E-01 |
| N0-vs-N2 |
7.220000E-01 |
| N1-vs-N2 |
6.443000E-01 |
|
|
